It was a great pleasure sharing our thoughts on how to create more impact with DLIs …. It starts with registering what we do .. ashpublications.org/hematology/a... #ASH26 @ash.hematology.org
Giving yourself a boost to keep going is also important for T cells fighting tumors.
The trick is to make them happy 😃 through costimulation that works not only in trans but also cis. #happyT-cell
www.nature.com/articles/s41...
Two main reasons: (1) Extracting γδTCRs and engineering them into other cell types creates versatile tools to target diverse cancers; (2) γδT cells have distinct homing and functional properties that can complement the arsenal of conventional αβ T cells.
www.nature.com/articles/s41...
@jkuball.bsky.social @sotnom.bsky.social @lydialynch.bsky.social @labminguet.bsky.social
🧬 Proud to share our latest review in Nature Cancer Reviews! Our article, "Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy", highlights a powerful but often overlooked player in the immunotherapy landscape.
rdcu.be/eo4RX
Major achievement of the GoCART Coalition and all authors to release the 2025 edition of the EU CAR-T handbook at #EBMT25. Thx to my co-editors, all authors, EBMT and EHA to support this amazing project that will allow to develop the CART passport! Enjoy reading 😀. www.ebmt.org/education/ca...
Still hot and happening: academic MSC for GVHD, a study of the CTIWP of The EBMT
rdcu.be/eaCcY
🚀 Fresh off the pre-proof! 🚀
Excited to share our latest work, now available in Blood Reviews
✅ Immune monitoring is widely implemented but still lacks standardization.
✅ There is an urgent need for harmonized protocols to optimize patient outcomes.
www.sciencedirect.com/science/arti...
Christian Chabannon presenting on the progress of #GoCARTcoalition a European initiative aiming to increase access to this exciting new therapies to cancer patients and patients with auto immune diseases. #EBMT #EHA #CART25
What a great pre meeting before #CART25 in Strassbourg of #T2Evolve and #GoCART coalition on developing consensus on collected CART data as well as registry interactions using OMOPing
We are proud to inform you that the survey about the CAR-T process has resulted in a stunning 227 response. Curious about first data: please join the session at QM Day April 1 at the EBMT congress in Florence, Italy!
#EBMT #JACIE #CART #GOCARTcoalition #HEMATOLOGY
lnkd.in/gQ8dQaps
www.nature.com/articles/s41.... Important consensus paper for centers using autologous stem cell transplant as treatment for Multiple Sclerosis
Congrats to the winners!!! Studies with real world data on CART are so important to improve clinical practice. Looking forward to the outcome of these studies thegocartcoalition.com
Proud of Anke Janssen who finalized her PhD on the biology of gdT cells and their receptors for cancer in immunotherapies. Yuca also to the co-promotors Dennis Beringer and Moniek de Witte
research.umcutrecht.nl/news/%CE%B3%...
Excellent presentation of @CChabannon on tisagenlecleucel for the Management of Patients with R/R DLBCL: an Interim Report of the European PASS Conducted
by EBMT at #ASH24
Thx for picking up our work on MSC for GVHD at #ASH24 …. Still an interesting option
#ASH24 Fantastic E. Donnall Thomas Lecture given by Sean Morrison on Hematopoietc Stem Cell Maintenance!
Dr. Ing Soo Tiong from @petermaccc.bsky.social presenting his excellent work at #ASH24 on how the remission clonal haematopoietic landscape is shaped by venetoclax in pts with AML. TP53 and BAX microclones! With a bit more sensitive sequencing tech we will find the nanoclones… #hemepath #hemesky
Starting #ASH24 on Bluesky 😎
